Cancer Therapy News and Research

RSS

Manhattan Scientifics' nano-electromagnetic sensing technology can detect MRD in leukemia

Manhattan Scientifics announced today that the National Cancer Institute (NCI) has funded a grant for its Senior Scientific, LLC unit, for the use of its proprietary, highly precise magnetic cancer cell measurement in leukemia research for determining the progress of cancer treatment.

14 Oct 2011

Mathematical optimization models to improve radiation therapy for cancer

Engineering researchers at the University of Arkansas have developed mathematical optimization models that will make radiation treatment plans safer and more efficient than conventional plans.

From Elekta 14 Oct 2011

Longer looks: Miss. ballot-initiative on abortion; personal fortune may have helped Herman Cain battle cancer; for doctors, breaking up is hard to do

One evening in late September John Perkins, a veteran of the civil-rights movement, attended a rally at a Baptist church in Jackson in support of what he called "a total justice issue," … It was concerned with Amendment 26, a measure on Mississippi's ballot this November that defines a person as being "every human being from the moment of fertilisation, cloning or the functional equivalent thereof". The reason for the measure is straightforward; its consequences less so. The Supreme Court, in its landmark Roe v Wade ruling in 1973, held that the right of a woman to terminate her pregnancy in the first trimester was guaranteed by her constitutional right to privacy.

14 Oct 2011

New technique stimulates stem cells after liver transplant to prevent rejection

Johns Hopkins researchers have developed a way to stimulate a rat's stem cells after a liver transplant as a means of preventing rejection of the new organ without the need for lifelong immunosuppressant drugs.

14 Oct 2011

Phyllodes tumors more prevalent among Hispanic women

According to a study published in the October issue of the Journal of the American College of Surgeons, phyllodes tumors - rare breast malignancies accounting for 0.5 to one percent of all breast tumors - tend to be more prevalent in Hispanic patients.

12 Oct 2011

First Edition: October 11, 2011

Today's headlines include reports about how Mitt Romney taking heat from the other GOP hopefuls, with some of the fire focusing on his Massachusetts health overhaul.

11 Oct 2011

Many cancer survivors continue to have poorer health years after completion of treatment

Forty-five per cent of cancer survivors in Northern Ireland suffer from physical and mental health problems years after their treatment has finished, according to new research from Macmillan Cancer Support and Queen's University Belfast.

11 Oct 2011

CXCL12 protein can inhibit metastasis of colon and melanoma cancers

Researchers at the Medical College of Wisconsin have shown that a protein can inhibit metastasis of colon and melanoma cancers. The findings are published in the October 10, 2011 issue of Proceedings of the National Academy of Sciences.

11 Oct 2011

FDA to review Banner's Bexarotene ANDA for CTCL skin cancer treatment

Banner Pharmacaps Inc. has confirmed that its Abbreviated New Drug Application for Bexarotene 75 mg soft gelatin capsules, a generic version of Targretin, has been accepted for review by the US Food and Drug Administration.

11 Oct 2011

A new approach to cancer treatment

Scientists have discovered a mechanism that causes an aggressive type of lung cancer to re-grow following chemotherapy, offering hope for new therapies.

9 Oct 2011

Scientists discover new metabolic pathway which makes gliomas more aggressive

A research alliance of Heidelberg University Hospital and the German Cancer Research Center, jointly with colleagues of the Helmholtz Center for Environmental Research in Leipzig, have discovered a new metabolic pathway which makes malignant brain tumors (gliomas) more aggressive and weakens patients' immune systems.

7 Oct 2011

Strain echocardiography can help physicians detect early signs of cardiac toxicity in cancer patients

There is good news for cancer patients whose medical treatments put them at risk for future cardiac problems: using strain echocardiography can help physicians detect early signs of cardiac toxicity.

7 Oct 2011

NIH Director to deliver keynote address at eighth SIO international conference

The Society for Integrative Oncology (SIO) announced today that National Institutes of Health Director Francis Collins, MD, PhD, will deliver the keynote address at its eighth international conference, which is co‐sponsored by Case Western Reserve University School of Medicine.

4 Oct 2011

Roundup: Blue Shield of Calif. drops coverage of controversial drug in breast cancer treatment; Perry presses stem cell therapy

Blue Shield of California will no longer pay for the use of the drug Avastin to treat breast cancer, a sign that support for the widely debated and expensive treatment may be eroding among health plans.

4 Oct 2011

IBA offers full line of Proton Therapy solutions for cancer specialty centers

IBA Particle Therapy now offers a range of Proton Therapy solutions for cancer specialty centers planning to treat from 250 to 2,000 patients annually with protons.

From Elekta 3 Oct 2011

Less toxic amounts of chemotherapy medicine slows tumor growth: Scientists

University of Georgia scientists have found that smaller, less toxic amounts of chemotherapy medicine given frequently to mice with human prostate cancer noticeably slowed tumor growth.

1 Oct 2011

Prostate cancer patients treated with CyberKnife Robotic Radiosurgery System enrolled in RPCR

The CyberKnife Coalition announced today that more than 500 men treated with the CyberKnife Robotic Radiosurgery System have now been enrolled in the first national patient registry designed specifically to track prostate cancer patients treated with stereotactic body radiation therapy.

1 Oct 2011

UAB Comprehensive Cancer Center receives NCI grant to renew support for cancer research program

The University of Alabama at Birmingham Comprehensive Cancer Center has received a five-year, $27.5 million Cancer Center Support Grant from the National Cancer Institute to renew support for its cancer research program through 2016.

1 Oct 2011

ALK gene discovered by St. Jude scientists associated with FDA approved adult cancer drug

A drug recently approved by the U.S. Food and Drug Administration for treatment of an adult cancer targets a malfunctioning gene discovered more than a decade earlier at St. Jude Children's Research Hospital. The story highlights how scientific findings from St. Jude can be translated into therapies and tests that in addition to helping children, also help adults.

30 Sep 2011

Kimmel Cancer Center at Jefferson celebrates two decades of caring and collaboration to beat cancer

From October forward, the Kimmel Cancer Center at Jefferson (KCC), a National Cancer Institute-designated cancer center, is celebrating 20 years of service to the community and the groundbreaking cancer research from the scientists and physicians who've provided an invaluable contribution to medical science and healthcare.

30 Sep 2011

Cancer Therapy News and Research

Manhattan Scientifics' nano-electromagnetic sensing technology can detect MRD in leukemia

Mathematical optimization models to improve radiation therapy for cancer

Longer looks: Miss. ballot-initiative on abortion; personal fortune may have helped Herman Cain battle cancer; for doctors, breaking up is hard to do

New technique stimulates stem cells after liver transplant to prevent rejection

Phyllodes tumors more prevalent among Hispanic women

First Edition: October 11, 2011

Many cancer survivors continue to have poorer health years after completion of treatment

CXCL12 protein can inhibit metastasis of colon and melanoma cancers

FDA to review Banner's Bexarotene ANDA for CTCL skin cancer treatment

A new approach to cancer treatment

Scientists discover new metabolic pathway which makes gliomas more aggressive

Strain echocardiography can help physicians detect early signs of cardiac toxicity in cancer patients

NIH Director to deliver keynote address at eighth SIO international conference

Roundup: Blue Shield of Calif. drops coverage of controversial drug in breast cancer treatment; Perry presses stem cell therapy

IBA offers full line of Proton Therapy solutions for cancer specialty centers

Less toxic amounts of chemotherapy medicine slows tumor growth: Scientists

Prostate cancer patients treated with CyberKnife Robotic Radiosurgery System enrolled in RPCR

UAB Comprehensive Cancer Center receives NCI grant to renew support for cancer research program

ALK gene discovered by St. Jude scientists associated with FDA approved adult cancer drug

Kimmel Cancer Center at Jefferson celebrates two decades of caring and collaboration to beat cancer

Your guide to microplate readers for cancer research eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News